CLASS ACTION UPDATE for ADMS, IRBT and AZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / December 11, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Adamas Pharmaceuticals, Inc. (NASDAQGM:ADMS)
ADMS Lawsuit on behalf of: investors who purchased August 8, 2017 – September 30, 2019
Lead Plaintiff Deadline: February 10, 2020
Join the action: https://www.zlk.com/pslra-1/adamas-pharmaceuticals-inc-loss-form?wire=3&prid=4828
Allegations: Adamas Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas's primary product, GOCOVRI, from their prescription formularies or requiring patients to use "step therapy" – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company's financial statements about Adamas's business, operations, and prospects were materially false and misleading at all relevant times.
To learn more about the Adamas Pharmaceuticals, Inc. class action, contact jlevi@levikorsinsky.com.
iRobot Corporation (NASDAQ:IRBT)
IRBT Lawsuit on behalf of: investors who purchased November 21, 2016 – October 22, 2019
Lead Plaintiff Deadline: December 23, 2019
Join the action: https://www.zlk.com/pslra-1/irobot-corporation-loss-form?wire=3&prid=4828
The filed complaint alleges that defendants misrepresented the reason for iRobot's acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company's largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company's channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.
To learn more about the iRobot Corporation class action, contact jlevi@levikorsinsky.com.
Azz, Inc. (NYSE:AZZ)
AZZ Lawsuit on behalf of: investors who purchased July 3, 2018 – October 8, 2019
Lead Plaintiff Deadline: January 3, 2020
Join the action: https://www.zlk.com/pslra-1/azz-inc-loss-form?wire=3&prid=4828
Allegations: During the class period, Azz, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's internal controls over financial reporting were not effective; (2) the Company improperly implemented ASC 606 which resulted in improper revenue reconciliations; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Azz, Inc. class action, contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
ReleaseID: 569876